Significant market consolidation is a central concern, with the top three health insurers and PBMs controlling 40% and 80% of their respective markets, raising questions about competition and patient impact.
Policymakers are actively pursuing legislative solutions at both state and federal levels to address rising costs and lack of transparency, citing examples like state insulin price caps and the proposed federal "Patients Deserved Price Tags Act".
Major insurers are implementing strategies to mitigate problems, with UnitedHealth Group reporting a 2% reduction in cost trends through value-based care and Cigna automating 78% of prior authorizations to reduce administrative burden.
There is a strong focus on increasing transparency for employers, who provide insurance for 61% of non-Medicare patients but often lack access to their own claims data, hindering cost management efforts.
10 quotes
Concerns Raised
Intense market consolidation in insurance and PBMs is reducing competition.
Rising healthcare costs are burdening families, seniors, and small businesses.
Lack of price and claims data transparency hinders effective cost management by employers.
Administrative burdens like prior authorization create barriers to patient care.
Opportunities Identified
Passing bipartisan legislation like the "Patients Deserved Price Tags Act" to increase transparency.
Expanding the use of value-based care models to lower systemic cost trends.
Leveraging automation to dramatically reduce the friction and delays associated with prior authorization.
Applying successful state-level policies, such as insulin price caps, at the federal level.